FT Vest Nasdaq-100 Buffer ETF – March (BATS:QMAR – Get Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totaling 69,357 shares, a growth of 93.4% from the September 30th total of 35,871 shares. Approximately 0.5% of the company’s shares are short sold. Based on an average daily volume of 8,143 shares, the short-interest ratio is presently 8.5 days.
Institutional Trading of FT Vest Nasdaq-100 Buffer ETF – March
Large investors have recently bought and sold shares of the company. Parallel Advisors LLC purchased a new position in shares of FT Vest Nasdaq-100 Buffer ETF – March during the 1st quarter worth approximately $378,000. Blue Bell Private Wealth Management LLC bought a new position in shares of FT Vest Nasdaq-100 Buffer ETF – March in the 3rd quarter worth approximately $34,000. Finally, Sunbelt Securities Inc. raised its position in shares of FT Vest Nasdaq-100 Buffer ETF – March by 2.3% in the 1st quarter. Sunbelt Securities Inc. now owns 13,286 shares of the company’s stock worth $447,000 after acquiring an additional 296 shares in the last quarter.
FT Vest Nasdaq-100 Buffer ETF – March Trading Down 0.6%
Shares of QMAR opened at $37.55 on Tuesday. FT Vest Nasdaq-100 Buffer ETF – March has a 1-year low of $31.91 and a 1-year high of $38.75. The firm’s 50-day moving average price is $38.17 and its 200-day moving average price is $36.16. The firm has a market capitalization of $544.48 million, a price-to-earnings ratio of 35.47 and a beta of 0.71.
About FT Vest Nasdaq-100 Buffer ETF – March
The FT Cboe Vest Nasdaq-100 Buffer ETF – March (QMAR) is an exchange-traded fund that is based on the NASDAQ 100 – USD index. The fund aims for specific buffered losses and capped gains on QQQ ETF over a specific holding period. The actively-managed fund holds options and collateral. QMAR was launched on Mar 19, 2021 and is managed by First Trust.
Recommended Stories
- Five stocks we like better than FT Vest Nasdaq-100 Buffer ETF – March
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for FT Vest Nasdaq-100 Buffer ETF - March Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FT Vest Nasdaq-100 Buffer ETF - March and related companies with MarketBeat.com's FREE daily email newsletter.
